We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Prodded to Push Bio-Innovation; Agency Eyes ‘Science Enclaves’
FDA Prodded to Push Bio-Innovation; Agency Eyes ‘Science Enclaves’
May 4, 2012
To boost biopharma innovation and U.S. competition in the sector, the FDA should incentivize precompetitive industry collaborations, promote public-private partnerships and wrap up integration of its information technology (IT) systems, a new Obama administration paper states.